183 related articles for article (PubMed ID: 38035663)
21. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
Wang X; Yang J; Yang F; Mu K
Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
[TBL] [Abstract][Full Text] [Related]
22. Single-cell sequencing and bulk RNA data reveal the tumor microenvironment infiltration characteristics of disulfidptosis related genes in breast cancer.
Chen Y; Jin C; Cui J; Diao Y; Wang R; Xu R; Yao Z; Wu W; Li X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12145-12164. PubMed ID: 37428249
[TBL] [Abstract][Full Text] [Related]
23. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
Qu J; Guan H; Zheng Q; Sun F
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
[TBL] [Abstract][Full Text] [Related]
24. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
[TBL] [Abstract][Full Text] [Related]
25. Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.
Zhao Y; Wei Y; Fan L; Nie Y; Li J; Zeng R; Li J; Zhan X; Lei L; Kang Z; Li J; Zhang W; Yang Z
Mol Med; 2023 Oct; 29(1):145. PubMed ID: 37884883
[TBL] [Abstract][Full Text] [Related]
26. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma.
Qi C; Ma J; Sun J; Wu X; Ding J
Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289
[TBL] [Abstract][Full Text] [Related]
27. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration.
Zhu A; Li X; Wang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16647-16658. PubMed ID: 37721569
[TBL] [Abstract][Full Text] [Related]
28. Development of the RF-GSEA Method for Identifying Disulfidptosis-Related Genes and Application in Hepatocellular Carcinoma.
Ni L; Yu Q; You R; Chen C; Peng B
Curr Issues Mol Biol; 2023 Nov; 45(12):9450-9470. PubMed ID: 38132439
[TBL] [Abstract][Full Text] [Related]
29. Disulfidptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Cancer.
Shi S; Tang X; Liu H
Reprod Sci; 2024 Mar; 31(3):811-822. PubMed ID: 37880552
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Model Construction of Disulfidptosis-Related Genes and Targeted Anticancer Drug Research in Pancreatic Cancer.
Duan H; Gao L; Asikaer A; Liu L; Huang K; Shen Y
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38575817
[TBL] [Abstract][Full Text] [Related]
31. A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma.
Xin S; Li R; Su J; Cao Q; Wang H; Wei Z; Li G; Qin W; Zhang Z; Wang C; Zhang C; Zhang J
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13925-13942. PubMed ID: 37541976
[TBL] [Abstract][Full Text] [Related]
32. Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.
Xue W; Qiu K; Dong B; Guo D; Fu J; Zhu C; Niu Z
Cancer Cell Int; 2023 Sep; 23(1):218. PubMed ID: 37759294
[TBL] [Abstract][Full Text] [Related]
33. Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature.
Wu Y; Shang J; Ruan Q; Tan X
Sci Rep; 2023 Oct; 13(1):17577. PubMed ID: 37845218
[TBL] [Abstract][Full Text] [Related]
34. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma.
Chen P; Yu J; Luo Q; Li J; Wang W
BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148
[TBL] [Abstract][Full Text] [Related]
35. Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.
Zhang Y; Ye Y; Xu A; Luo Y; Sun Y; Zhang W; Ji L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11979-11994. PubMed ID: 37422541
[TBL] [Abstract][Full Text] [Related]
36. Disulfidptosis: a new target for metabolic cancer therapy.
Zheng P; Zhou C; Ding Y; Duan S
J Exp Clin Cancer Res; 2023 Apr; 42(1):103. PubMed ID: 37101248
[TBL] [Abstract][Full Text] [Related]
37. Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer.
Liu L; Liu J; Lyu Q; Huang J; Chen Y; Feng C; Liu Y; Chen F; Wang Z
Sci Rep; 2023 Aug; 13(1):12470. PubMed ID: 37528124
[TBL] [Abstract][Full Text] [Related]
38. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer.
Li Y; Tang M; Dang W; Zhu S; Wang Y
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13995-14014. PubMed ID: 37543978
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.
Ye Y; Hu Q; Chen H; Liang K; Yuan Y; Xiang Y; Ruan H; Zhang Z; Song A; Zhang H; Liu L; Diao L; Lou Y; Zhou B; Wang L; Zhou S; Gao J; Jonasch E; Lin SH; Xia Y; Lin C; Yang L; Mills GB; Liang H; Han L
Nat Metab; 2019 Apr; 1(4):431-444. PubMed ID: 31984309
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer.
Li Q; Yin LK
World J Clin Oncol; 2023 Oct; 14(10):373-399. PubMed ID: 37970110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
